6933 related articles for article (PubMed ID: 3065655)
1. Biological and immunological properties of the HMB-2 human melanoma cell line.
Svec J; Veselovská Z; Keszeghová V; Matoska J; Marchetti A; Squartini F
Neoplasma; 1988; 35(6):665-81. PubMed ID: 3065655
[TBL] [Abstract][Full Text] [Related]
2. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
3. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
[TBL] [Abstract][Full Text] [Related]
5. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
8. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
[TBL] [Abstract][Full Text] [Related]
10. Cell surface antigens of human uveal melanoma identified by monoclonal antibodies.
Kalafut F; Kusenda J; Novotná L; Cernák A
Czech Med; 1988; 11(2):73-80. PubMed ID: 3137006
[TBL] [Abstract][Full Text] [Related]
11. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor.
Fetsch PA; Fetsch JF; Marincola FM; Travis W; Batts KP; Abati A
Mod Pathol; 1998 Aug; 11(8):699-703. PubMed ID: 9720495
[TBL] [Abstract][Full Text] [Related]
12. Clonal variation in the production of tumor-associated alpha 2-macroglobulin in a malignant human melanoma and association with growth stimulation.
Bízik J; Lizonová A; Grófová M; Matoŝka J; Doré JF; Bertrand S; Blaŝko M; Vaheri A
Cancer Res; 1989 Feb; 49(4):983-90. PubMed ID: 2463878
[TBL] [Abstract][Full Text] [Related]
13. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
Fukaya T; Hashimoto K; Eto H; Mehregan A
Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of inhibiting the lymph node metastasis in human gastric carcinoma by B7-1 gene transfection.
Sakate Y; Yashiro M; Tanaka H; Sunami T; Kosaka K; Hirakawa K
J Surg Res; 2004 Nov; 122(1):89-95. PubMed ID: 15522320
[TBL] [Abstract][Full Text] [Related]
15. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
Hearing VJ; Gersten DM; Montague PM; Vieira WD; Galetto G; Law LW
J Immunol; 1986 Jul; 137(1):379-84. PubMed ID: 3711669
[TBL] [Abstract][Full Text] [Related]
16. Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma.
Epstein AL; Martin AO; Kempson R
Cancer Res; 1984 Mar; 44(3):1265-74. PubMed ID: 6362860
[TBL] [Abstract][Full Text] [Related]
17. Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.
Khan A; Grammer S; Chang D; Hill NO; Miller J
Cancer Res; 1983 Dec; 43(12 Pt 1):5868-72. PubMed ID: 6196109
[TBL] [Abstract][Full Text] [Related]
18. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium.
Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM
Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918
[TBL] [Abstract][Full Text] [Related]
19. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
[TBL] [Abstract][Full Text] [Related]
20. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.
Adema GJ; de Boer AJ; van 't Hullenaar R; Denijn M; Ruiter DJ; Vogel AM; Figdor CG
Am J Pathol; 1993 Dec; 143(6):1579-85. PubMed ID: 7504884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
